An untold story?

BMJ

Volumn 336, Issue 7643, 2008, Pages 532-534

  Lenzer, Jeanne ^a   Brownlee, Shannon ^b  

^a New America Foundation ^*

^b NEW AMERICA FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; SERTRALINE; VALDECOXIB;

ARTICLE; DRUG INFORMATION; DRUG MARKETING; DRUG MONITORING; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; MEDICAL STAFF; PATIENT ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; REFERENCE DATABASE; RISK ASSESSMENT; TREATMENT WITHDRAWAL;

EID: 40949123936     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39504.662685.0f     Document Type: Article

References (11)

1. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5(2):e45 doi: 10.1371/journal.pmed.0050045.
2. Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based? Lancet 2007;369:168-9.
3. Jüni P, Reichenbachs, Egger M. COX 2 inhibitors, traditional NSAIDs, and the heart. BMJ 2005;330:1342-3.
4. Groves T. Mandatory disclosure of trial results for drugs and devices. BMJ 2008;336:170.
5. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
6. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. JAMA 1999;281:1110-1.
7. Bracken MB, Shepard MI, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National acute spinal cord injury study. JAMA 1997;277:1597-1604.
8. Lenzer J. NIH secrets: study break. New Republic 2006 Oct 30. www.ahrp.org/cms/index2.php?option=com_content&do_pdf=1&id=398.
9. Lenzer J. Drug secrets: what the FDA isn't telling. Slate 2005 Sep 27. www.slate.com/id/2126918/.
10. Waknine Y. Bextra withdrawn from market. Medscape Today 2005 Apr 7. www.medscape.com/viewarticle/502642?rss.
11. Public Citizen Health Research Group versus FDA-complaint (26 Feb 2004). www.citizen.org/documents/ACF5CF.pdf.